Skip to main content
. 2021 Feb 18;6(2):e003618. doi: 10.1136/bmjgh-2020-003618

Table 2.

Study characteristics of studies assessing in-hospital mortality

Author (year)+Country Study design Duration of study (months) Study participants and sample size Setting Intervention Control Mortality as primary outcome Duration of hospital stay in days (mean±SD)
POSTNATAL INTERVENTIONS
Feeding interventions
Feeding schedule Tali et al67 (2016)
India
RCT NA Neonates weighing 501–1500 g/intervention: 60, control: 60 Level III NICU 3-hour feeding schedule (eight feeds daily) 2-hour feeding schedule (12 feeds daily) No Intervention: 46±21.5, control: 43.7±20.2
Infection prevention
Granulocyte stimulation Aktas et al48 (2015)
Turkey
RCT 24 Neutropenic preterm neonates* with culture-proven or suspected sepsis/intervention: 33, control: 23 Teaching hospital Recombinant human granulocyte-macrophage colony-stimulating factor (rhG-CSF) 10 mg/kg/day in 5% dextrose until absolute neutrophil count reached >1.0×109/L Empirical antibiotics alone Yes Not reported
Pro/synbiotic supplements Nandhini et al62 (2016)
India
RCT NA Enterally fed preterm neonates with gestational age 28–34 weeks and birth weight >1000 g/intervention: 110 (analysed: 108), control: 110 Paediatrics department of a tertiary hospital Synbiotics supplement: Lactobacillus acidophilus, Bifidobacterium longum, Lactobacillus rhamnosus, Lactobacillus plantaris, Lactobacillus casei, Lactobacillus bulgaricus, Bifidobacterium infantis, Bifidobacterium breve and 100 mg of fructo-oligosaccharide (prebiotic) Standard care No Intervention: 8.3±4.5, control: 8.4±5.1
Sari et al64 (2011)
Turkey
RCT 9 Preterm neonates with a gestational age <33 weeks or birth weight <1500 g, who survived to feed enterally/intervention: 121 (analysed: 110), control: 121 (analysed: 111) NICU of a training hospital Feeding with oral probiotic Lactobacillus sporogenes 350 000 000 colony-forming unit once a day Breast milk or formula alone Yes Death >7 days intervention: 43.5, control: 30
Prevention and treatment of respiratory morbidity
CPAP Bhatti et al52 (2015)
India
RCT 19 Preterm neonates <34 weeks of gestation with respiratory distress within 6 hours of life/intervention: 80, control: 90 Two level III NICU’s Nasal-jet CPAP device: a variable flow CPAP device with a Benveniste valve that generates CPAP at the level of the nostril with a short binasal prong as nasal interface Bubble CPAP No Not reported
Mazmanyan et al60 (2016)
Armenia
RCT NA Preterm neonates/ intervention: 66, control: 59 Neonatal unit Bubble CPAP Flow driver CPAP No Not reported
Okello et al63 (2019)
Uganda
Pre–post intervention trial 32 VLBW† neonates/preintervention: 158, postintervention: 219 Neonatal unit of a regional referral hospital Bubble CPAP Preintervention period Yes Median (IQR) preintervention: 8 (2, 17), postintervention: 9.5 (4, 19)
Say et al65 (2016)
Turkey
RCT 7 Preterm infants with gestation 26–32 weeks and IRDS/intervention: 75, control: 74 NICU of a teaching hospital Binasal prong for applying CPAP Nasal mask for applying nasal CPAP No Median (IQR) intervention: 18 (10–21), control: 25 (20–28)
Tagare et al66 (2013)
India
RCT 13 Preterm neonates with IRDS and oxygen requirement >30% within first 6 hours of life/intervention: 57, control: 57 NICU of a tertiary hospital Bubble CPAP Ventilator-derived CPAPNot reported No Not reported
Exogenous surfactant replacement therapy Gharehbaghi et al54 (2010)
Iran
RCT 13 Preterm infants with IRDS that required exogenous surfactant replacement therapy/intervention: 79, control: 71 Level III NICU of a university hospital Poractant alfa 200 mg/kg in two divided doses Beractant 100 mg/kg in four divided doses No Intervention: 24.9±26.4, control: 29.1±23.5
Halim et al56 (2018)
Pakistan
RCT 8 Preterm neonates at <34 weeks of gestation with IRDS/intervention: 50, control: 50 Neonatal unit of a tertiary hospital Less invasive surfactant administration (LISA) method: surfactant was administered at a dose of 100 mg/kg of Survanta with the help of size 6Fr nasogastric tube Conventional INSURE method: INtubation SURfactant administration and Extubation No Median (IQR) intervention: 7 (5), control: 6 (4)
Jain et al57 (2019)
India
RCT 19 Preterm neonates born at 26–32 weeks’ gestation with clinical features of IRDS ≤6 hours of birth and fulfilled criteria for surfactant therapy ≤24 hours of birth/intervention: 53 (analysed: 52), control: 48 (analysed: 46) NICUs of seven tertiary care centres Goat lung surfactant extract Beractant Yes Intervention: 31.6±32.0, control: 31.7±21.9
Feeding supplementation Basu et al51 (2019)
India
RCT 20 VLBW neonates requiring respiratory support in the form of oxygen inhalation, CPAP, high flow nasal cannula (HFNC), or mechanical ventilation at the age of 24 hours/ intervention: 98, control: 98 NICU of a tertiary care teaching hospital Oral vitamin A 1 mL of syrup (10 000 IU of retinol/dose) on alternate day for 28 days, starting at 24 hours of life Placebo No Death was recorded at 36 weeks post menstrual age
Oxygen systems other than CPAP Graham et al55 (2019)
Nigeria
Stepped-wedge cluster RCT 44 All children (aged <15 years), admitted to participating hospitals. LBW‡, preterm/ preintervention: 1883, pulse oximetry: 688, full O2 system: 1137 Twelve general, paediatric, and maternity hospitals in southwest Nigeria
  • Pulse oximetry to improve clinical use of oxygen targeting hypoxaemic neonates

  • Full O2 system involving (1) a standardised oxygen equipment package, (2) clinical education and support, (3) technical training and support, and (4) infrastructure and systems support

Preintervention period Yes Not reported
Krishna et al58 (2019)
India
RCT 17 Preterm neonates with gestational age of 27–34 weeks, ventilated within the first week of life for IRDS/intervention: 40, control: 41 Level III NICU of a tertiary hospital Volume-guaranteed ventilation (VGV) Pressure-controlled ventilation No Not reported
Murki et al61 (2018)
India
RCT 13 Preterm infants with gestational age of ≥28 weeks and birth weight ≥1000 g, with respiratory distress/intervention: 133, control: 139 NICUs of two tertiary care hospitals High-flow nasal cannula (HFNC) as a primary non-invasive respiratory support Nasal CPAP No Intervention: 18±13, control: 17±14
Prophylactic methylxanthines Kumar et al59 (2017)
India
RCT 24 Preterm neonates with gestational age of ≤30 weeks, who were intubated for ≥24 hours/intervention: 78 (analysed: 70), control: 78 (analysed: 73) NICU of a tertiary hospital Aminophylline: loading dose of 5 mg/kg, followed by a maintenance dose of 1.5 mg/kg Q8h via injection and oral preparation of 10 mg/mL of theophylline Caffeine: a loading dose of 20 mg/kg of caffeine citrate and continued on a maintenance dose of 5 mg/kg Q24h via (IV or oral) No Duration of NICU stay median (25th percentile, 75th percentile)/intervention: 34 (14.8, 48.3), control: 38 (21, 55)
Strategies of newborn care
Maternal nursing care Arif et al49 (1999)
Pakistan
RCT 6 Babies weighing 1000–2000 g on admission irrespective of sex or age/intervention: 160 (analysed: 151), control: 240 (analysed: 211) Neonatal ward of a government children’s hospital Maternal nursing care Special care baby unit, looked after entirely by nurses Yes Not reported
Bhutta et al53 (2004)
Pakistan
Pre–post intervention trial 98 VLBW infants/intervention: 318, control: 191 Neonatal unit of a tertiary hospital A stepdown unit (involvement of maternal nursing care) Preintervention period Yes Intervention: 15.4±15.7, control: 22.2±21.7
Others
Strategies for PDA closure Balachander et al50 (2018)
India
RCT 16 Preterm neonates with PDA of size ≥1.5 mm and left to right shunt after 24 hours of life/intervention: 55, control: 55 Neonatal unit of a tertiary hospital Oral paracetamol for PDA closure: 15 mg/kg/dose 6-hourly by oro-gastric tube or paladai for 2 days Oral ibuprofen: 10 mg/kg stat on day 1 followed by 5 mg/kg 24 hours for 2 days No Intervention: 21.4±11.8, control: 25.7±15.1
Hypothermia prevention Van Den Bosch et al68 (1996)
Malawi
RCT 4 Neonates with a birth weight of 800–1500 g and Apgar score >7/intervention: 33 (analysed: 15), control: 32 (analysed: 11) Neonatal nursery of a tertiary hospital Polythene tobacco-wrap folded double with one thickness above and two thicknesses tucked below the baby Standard nursing procedure No Intervention: 29.4 (95% CI 1.0 to 57.8), control: 14 (–9.6 to 37.6)

*Preterm neonate=<37 weeks of gestation.

†VLBW=very low birth weight (<1500 g).

‡LBW=low birth weight (<2500 g).

CPAP, continuous positive airway pressure; HFNC, high flow nasal cannula; INSURE, INtubation SURfactant administration and Extubation; IRDS, infant respiratory distress syndrome; IV, intravenous; LISA, less invasive surfactant administration; NICU, neonatal intensive care unit; PDA, patent ductus arteriosus; RCT, randomised controlled trial; rhG-CSF, recombinant human granulocyte-macrophage colony-stimulating factor; VGV, volume-guaranteed ventilation.